Moffitt Cancer Center
Money, marketing and inclusion needed to ‘eradicate that gap’ in health care disparities
Robert A. Winn, MD, FAACR, first called for celebration.
HPV vaccination linked to lower risk for related cancers among men
Men vaccinated for HPV less frequently developed all related cancers, particularly head and neck cancers, according to findings scheduled for presentation at ASCO Annual Meeting.
Lifileucel approval the start of a ‘glorious future’ for cell therapy in solid tumors
It took more than 35 years for tumor-infiltrating lymphocytes, which Steven A. Rosenberg, MD, PhD, and colleagues first reported on in 1988 for the treatment of advanced melanoma, to progress enough to gain FDA approval.
Blood tests may predict which patients with lymphoma will have poor outcomes after CAR-T
Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.
‘Compelling evidence’ shows neoadjuvant chemotherapy improves survival in penile cancer
Neoadjuvant chemotherapy followed by consolidative lymphadenectomy provided a significant survival benefit among adults with locally advanced penile squamous cell carcinoma who responded to treatment, study results suggest.
‘Call to action’: Research needed on impact of extreme weather events on cancer care
Hurricane Ian hit Lisa M. Gudenkauf, PhD, MPH, hard.
Model uses AI to predict prognosis for patients newly diagnosed with multiple myeloma
Researchers at several institutions collaborated to develop the first computational model that predicts prognosis for patients newly diagnosed with multiple myeloma based on tumor genomics and treatments.
‘Robust efficacy’ of triplet therapy offers ‘a new standard’ for advanced multiple myeloma
A triplet therapy showed significant improvement in PFS compared with the current standard-care regimen among patients with relapsed or refractory multiple myeloma, according to data presented during an ASCO Plenary Series session.
Marijuana use associated with lower rates of prostate cancer
Active and former marijuana users reported significantly lower prevalence of prostate cancer compared with nonusers, according to data presented at ASCO Genitourinary Cancers Symposium.
Findings may help resolve ‘active debate’ about adjuvant radiotherapy for breast cancer
SAN ANTONIO — Treatment de-escalation may be possible for patients with breast cancer who respond well to neoadjuvant chemotherapy, according to randomized phase 3 study results presented at San Antonio Breast Cancer Symposium.